BRUSSELS: Europe’s stuttering vaccine rollout faced multiple hurdles on Friday (Saturday in Manila) as European Union regulators said they were reviewing side effects of the Johnson & Johnson shot and France further limited its use of the AstraZeneca jab.
The US drugs regulator said it had not found a “causal” link between the J&J vaccine and blood clots, but that its probe was continuing after “a few individuals” suffered complications.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.